Pyroptosis is a form of programmed cell death that kills the cell by punching holes in its outer membrane, causing it to swell, burst, and spill its inflammatory contents into surrounding tissue. Unlike the quiet, tidy death of apoptosis, pyroptosis is loud and deliberate: it alerts the immune system by releasing signaling molecules that recruit more immune cells and amplify inflammation. The process depends on a family of pore-forming proteins called gasdermins, and while it serves as a frontline defense against infection, the same machinery can drive serious disease when it fires inappropriately or excessively.
How the Canonical Pathway Works
The best-studied route to pyroptosis starts inside immune cells like macrophages when they detect something dangerous in their interior. Sensors belonging to a group of proteins called pattern-recognition receptors pick up on bacterial components, toxins, or signals of cellular damage. Once triggered, these sensors assemble into a large multi-protein structure called the inflammasome. Key inflammasome-forming sensors include NLRP1, NLRP3, and NLRC4, which connect to an adaptor protein called ASC that serves as a scaffold for the complex.1PubMed Central. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis
The inflammasome’s job is to activate an enzyme called caspase-1. Once switched on, caspase-1 does two things simultaneously. First, it processes the precursor forms of two inflammatory signaling molecules, IL-1β and IL-18, into their active, mature versions. Second, it cleaves a protein called gasdermin D (GSDMD), splitting it into two fragments. The freed N-terminal fragment is the weapon: it travels to the cell’s inner membrane surface and begins assembling into a ring-shaped pore. That pore is the defining event of pyroptosis. It allows the processed cytokines to escape the cell and, as more pores accumulate, the cell loses control of what flows in and out.1PubMed Central. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis
The Non-Canonical Pathway
The canonical pathway responds to a broad range of danger signals, but a second, “non-canonical” route exists specifically to catch one threat: bacterial molecules called lipopolysaccharide (LPS) that have made it inside the cell. LPS is a major component of the outer membrane of Gram-negative bacteria, and its presence in the cytoplasm signals that bacteria have invaded or broken apart inside the cell. Rather than going through an inflammasome and caspase-1, cytoplasmic LPS binds directly to a different set of enzymes: caspase-4 and caspase-5 in humans, or caspase-11 in mice.2PubMed Central. Caspase-11 non-canonical inflammasome: a critical sensor of intracellular lipopolysaccharide in macrophage-mediated inflammatory responses
When LPS binds these caspases, they rapidly cluster together and activate. The activated caspases then cleave gasdermin D directly, producing the same membrane-puncturing N-terminal fragment as the canonical route.3The Journal of Immunology. Function and Regulation of Noncanonical Caspase-4/5/11 Inflammasome The outcome is the same: pore formation, cell swelling, and inflammatory death. But the non-canonical pathway also feeds back into the canonical one. Gasdermin D pores allow potassium to leave the cell, and that potassium drop can activate the NLRP3 inflammasome, which then turns on caspase-1 and triggers processing of IL-1β and IL-18. So the two pathways are not entirely separate: the non-canonical route handles LPS detection, then recruits canonical machinery for full cytokine release.2PubMed Central. Caspase-11 non-canonical inflammasome: a critical sensor of intracellular lipopolysaccharide in macrophage-mediated inflammatory responses
What the Gasdermin Pore Looks Like
Structural studies using cryo-electron microscopy have revealed the gasdermin pore in striking detail. The GSDMD pore typically consists of about 33 protein subunits arranged in a ring, with an inner diameter of roughly 21.5 nanometers and an outer diameter of around 31 nanometers. Each subunit contributes two hairpin-shaped loops that plunge through the cell membrane, forming a barrel of over a hundred interlocking strands.4PubMed Central. Mechanistic insights into gasdermin pore formation and regulation in pyroptosis This barrel is tall enough to span the full thickness of the lipid membrane. Its outer surface is greasy, fitting snugly among the membrane’s fatty molecules, while the inner channel is lined with residues that allow water-soluble molecules to pass through.
A related gasdermin, GSDMA3, forms slightly smaller pores of 27 to 28 subunits. Structural work on this pore revealed a positively charged helix on each subunit that grabs onto cardiolipin, an acidic lipid concentrated on the inner leaflet of cell membranes. This lipid preference helps explain why gasdermin pores form on the host cell’s own membrane but generally spare neighboring cells: the pore-forming fragment targets specific lipid compositions.5PubMed Central. Cryo-EM structure of the gasdermin A3 membrane pore The same studies captured a “double-ring” structure in which a second ring of gasdermin subunits sits on top of the membrane-inserted ring without penetrating the bilayer, possibly representing a preparatory stage before the pore fully assembles.
From Pore to Rupture
Gasdermin pores alone do not fully destroy the cell. They are large enough to let processed cytokines and small molecules pass through, and experiments have shown that IL-1β can escape through GSDMD pores even when the cell itself remains intact.6Immunity. Gasdermin D Pores Permit Cytokine Release in the Absence of Pyroptosis in Macrophages But if pore formation continues unchecked, the cell eventually loses osmotic balance, swells, and its plasma membrane tears apart. Recent research has identified a second protein, NINJ1 (ninjurin-1), as the executioner of that final rupture. NINJ1 mediates membrane destruction through a fundamentally different mechanism: rather than forming a defined channel, it cuts the membrane into disk-shaped fragments, leading to catastrophic membrane loss.7PubMed Central. NINJ1 mediates plasma membrane rupture by cutting and releasing membrane disks
This two-step architecture matters. In the early phase, gasdermin pores allow controlled release of inflammatory cytokines. In the late phase, NINJ1-driven rupture releases everything else inside the cell: large proteins, DNA fragments, and a class of molecules collectively called damage-associated molecular patterns, or DAMPs. One of the most studied DAMPs released during pyroptosis is HMGB1, a nuclear protein that, once outside the cell, acts as a potent alarm signal, attracting more immune cells to the site.8PubMed Central. TLR activation regulates damage-associated molecular pattern isoforms released during pyroptosis HMGB1 release is not unique to pyroptosis; it also occurs in necrosis, necroptosis, and several other forms of cell death.9PubMed Central. The mechanism of HMGB1 secretion and release But the inflammatory context of pyroptosis makes the combination of processed IL-1β, IL-18, and DAMPs a particularly strong pro-inflammatory cocktail.
Defending Against Intracellular Bacteria
The reason this violent form of cell death exists at all is that some pathogens hide inside host cells, where antibodies and many immune defenses cannot reach them. By destroying its own membrane, a pyroptotic cell expels the bacteria it was harboring, exposing them to neutrophils and other immune cells waiting outside. At the same time, the released cytokines recruit reinforcements.10PubMed Central. Pyroptosis in defense against intracellular bacteria
The protective value of pyroptosis has been demonstrated convincingly in animal models of Salmonella infection. In intestinal epithelial cells, both the canonical and non-canonical inflammasome pathways contribute to controlling Salmonella Typhimurium. Mice lacking both caspase-1 and caspase-11, and therefore unable to undergo pyroptosis, fail to control the bacteria. The NAIP/NLRC4 inflammasome in the gut epithelium appears to eliminate the intracellular niche that Salmonella needs to replicate, and in doing so also protects the animals from a harmful inflammatory overreaction driven by tumor necrosis factor.11Disease Models & Mechanisms. Pyroptosis in host defence against bacterial infection
When Pyroptosis Fuels Disease
The same inflammatory power that clears infections can cause collateral damage when the pathway is triggered too easily, too broadly, or for too long. This dark side of pyroptosis shows up across a surprising range of diseases.
Viral Hyperinflammation and COVID-19
SARS-CoV-2 infection provided a large-scale example of pyroptosis turning harmful. The virus can trigger excessive immune activation, including a flood of inflammatory cytokines known as cytokine storm. Research has linked pyroptosis in macrophages and other immune cells to this process. Pyroptotic cell death disrupts immune system balance, leaks inflammatory contents, and exacerbates tissue damage in the lungs and elsewhere.12PubMed Central. Pyroptotic cell death in SARS-CoV-2 infection: revealing its roles during the immunopathogenesis of COVID-19 Single-cell transcriptomic analysis of COVID-19 patients found that expression of pyroptosis-associated genes, including IL-1β and IL-18, was markedly higher in moderate and severe cases compared to healthy controls. The effect was most pronounced in macrophages and neutrophils rather than T cells or B cells. Overexpression of NINJ1 in macrophages of severe patients suggests that full membrane rupture, not just pore formation, contributes to the amplification of systemic inflammation.13ImmunoInformatics. Association of pyroptosis and severeness of COVID-19 as revealed by integrated single-cell transcriptome data analysis
Autoinflammatory Syndromes
Some people carry gain-of-function mutations in NLRP3, the most broadly studied inflammasome sensor. These mutations cause the inflammasome to fire spontaneously, producing chronic episodes of fever, rash, and joint inflammation known as cryopyrin-associated periodic syndromes (CAPS). Beyond these rare genetic conditions, dysregulated NLRP3 activity has also been linked to more common diseases, including gout, cardiovascular disease, and liver disease.14PubMed Central. The discovery of NLRP3 and its function in cryopyrin-associated periodic syndromes and innate immunity
Atherosclerosis
In blood vessels, pyroptosis contributes to the chronic inflammation that underlies atherosclerosis. Macrophages that engulf cholesterol in artery walls can activate inflammasomes, undergo pyroptosis, and release their inflammatory payload directly into the arterial plaque. This process drives plaque growth and instability, increasing the risk of rupture and heart attack.15PubMed Central. The Molecular Pathways of Pyroptosis in Atherosclerosis
Neurodegeneration
In the brain, microglia (the resident immune cells of the central nervous system) can undergo NLRP3-driven pyroptosis. In Parkinson’s disease, this inflammasome activation in microglia drives neuroinflammation and contributes to the death of dopamine-producing neurons. Animal studies have shown that blocking NLRP3 can slow disease progression and improve motor function, suggesting the pathway is not merely a bystander but an active participant in neuronal damage.16PubMed Central. Research progress on microglial pyroptosis and inflammasomes: a comprehensive analysis
Pyroptosis in Cancer
The relationship between pyroptosis and cancer is genuinely two-faced. On one hand, pyroptosis can help fight tumors. When cancer cells undergo pyroptotic death, they release DAMPs and inflammatory mediators that can wake up the immune system and promote anti-tumor immunity. This makes pyroptosis an appealing target for cancer immunotherapy, particularly in tumors that have evolved to suppress immune responses. By triggering pyroptosis specifically in tumor cells, researchers hope to turn immunologically “cold” tumors into “hot” ones that attract immune attack.17PubMed Central. Targeting pyroptosis for cancer immunotherapy: mechanistic insights and clinical perspectives
On the other hand, chronic pyroptotic inflammation in the tumor microenvironment can promote tumor growth and metastasis. Persistent inflammatory signaling can suppress effective immune responses, encourage blood vessel formation that feeds the tumor, and create a tissue environment that favors cancer cell survival. The challenge for researchers is figuring out how to trigger pyroptosis in a controlled, targeted way that helps rather than harms.
The Caspase-3 Crossover
A third route to pyroptosis was discovered more recently, and it blurs the boundary between pyroptosis and apoptosis. When cells undergo apoptosis (the “clean” form of cell death), caspase-3 is one of the key executioner enzymes. Normally, caspase-3 dismantles the cell quietly. But in cells that express a gasdermin family member called GSDME (originally identified in families with hereditary deafness and known as DFNA5), caspase-3 can cleave GSDME in the same way that caspase-1 cleaves GSDMD. The resulting fragment punches pores in the membrane and converts what started as apoptosis into full-blown pyroptosis.18PubMed. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
This crossover has real clinical implications. Many chemotherapy drugs and the inflammatory molecule TNF kill cells through caspase-3. If the dying cells express GSDME, that apoptotic death switches to pyroptosis, producing inflammation. This may explain some of the severe inflammatory side effects of certain chemotherapy regimens: the drugs are not just killing cancer cells but triggering an inflammatory form of death in normal tissues that express GSDME. It also raises the possibility that manipulating GSDME expression could make tumors more visible to the immune system by switching their death from silent to inflammatory.
Drugs That Target the Pathway
Because pyroptosis drives inflammation in so many diseases, there is strong interest in drugs that can dial it down. Several compounds have shown promise in preclinical work. MCC950 is a selective NLRP3 inhibitor that blocks inflammasome assembly. VX-765 inhibits caspase-1, preventing both cytokine processing and gasdermin D cleavage. Dimethyl fumarate, already approved for multiple sclerosis, also appears to interfere with pyroptotic signaling.19PubMed. Pharmaceutical therapies for pyroptosis in lung injury
Perhaps the most intriguing candidate is disulfiram, a drug used for decades to treat alcohol addiction. Researchers discovered that disulfiram directly blocks gasdermin D pore formation at nanomolar concentrations by chemically modifying a single cysteine residue on the protein. It does not prevent gasdermin D from being cleaved; rather, it stops the freed fragment from assembling into functional pores. In mouse models of sepsis triggered by LPS, disulfiram prevented the lethal inflammatory cascade.20PubMed Central. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation Because disulfiram already has a long safety record in humans, it is a prime candidate for repurposing, though clinical trials specifically targeting inflammatory diseases through this mechanism are still in early stages.
Fine-Tuning by the Cell’s Own Machinery
The cell does not rely solely on whether an inflammasome fires or not. Multiple layers of chemical modification act as rheostats on the pyroptotic machinery. Post-translational modifications, where the cell’s enzymes attach or remove small chemical groups to proteins after they are made, can alter whether inflammasome components assemble, whether gasdermins can be cleaved, and whether pores successfully form.21PubMed Central. The regulation of pyroptosis by post-translational modifications: molecular mechanisms and therapeutic targets These modifications include phosphorylation, ubiquitination, and others, and they provide the cell with a way to raise or lower the threshold for pyroptosis depending on context. This built-in regulation is one reason the pathway does not fire constantly even in tissues exposed to low-grade danger signals.
Reactive oxygen species (ROS), the chemically reactive molecules generated as byproducts of metabolism and during immune responses, also influence whether pyroptosis proceeds. ROS can act as triggers when they exceed certain thresholds, promoting inflammasome activation and pushing the cell toward death. But their role is not one-directional: depending on the type, location, and amount, ROS can also suppress specific cell death pathways.22PubMed Central. Reactive Oxygen Species Across Death Pathways: Gatekeepers of Apoptosis, Ferroptosis, Pyroptosis, Paraptosis, and Beyond This complexity means that conditions which generate oxidative stress, from mitochondrial dysfunction to chronic infection, can shift the balance toward more pyroptotic death in ways that are difficult to predict from any single variable.
An Ancient Form of Cellular Suicide
Pyroptosis might seem like a sophisticated mammalian trick, but gasdermin-family proteins are far older than mammals. Functional gasdermins have been found in bony fish, corals, fungi, and even bacteria. These organisms use gasdermin-like proteins to execute cell death in ways that parallel what happens in human immune cells, suggesting that the basic strategy of punching holes in your own membrane as a defense mechanism dates back hundreds of millions of years.23PubMed. Gasdermin and Gasdermin-Like Pore-Forming Proteins in Invertebrates, Fungi and Bacteria In bacteria, these systems appear to function as “abortive infection” programs, where a single bacterium kills itself to prevent a viral infection from spreading to its neighbors. The conceptual parallel is striking: sacrifice one cell to protect the community, whether that community is a bacterial colony or a human tissue.